13.70
Schlusskurs vom Vortag:
$13.19
Offen:
$13.22
24-Stunden-Volumen:
156.59K
Relative Volume:
0.69
Marktkapitalisierung:
$150.58M
Einnahmen:
$1.07B
Nettoeinkommen (Verlust:
$99.41M
KGV:
1.5121
EPS:
9.06
Netto-Cashflow:
$141.17M
1W Leistung:
+5.71%
1M Leistung:
-4.86%
6M Leistung:
-14.54%
1J Leistung:
-28.23%
Medifast Inc Stock (MED) Company Profile
Firmenname
Medifast Inc
Sektor
Branche
Telefon
(732) 764-0619
Adresse
11445 CRONHILL DRIVE, OWINGS MILLS, MD
Vergleichen Sie MED mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
MED
Medifast Inc
|
13.70 | 141.02M | 1.07B | 99.41M | 141.17M | 9.06 |
![]()
ROL
Rollins Inc
|
58.12 | 28.05B | 3.46B | 477.23M | 599.93M | 0.99 |
![]()
SCI
Service Corp International
|
82.05 | 11.33B | 4.22B | 530.23M | 639.52M | 3.64 |
![]()
BFAM
Bright Horizons Family Solutions Inc
|
119.58 | 6.71B | 2.63B | 116.59M | 215.93M | 1.99 |
![]()
HRB
H R Block Inc
|
49.92 | 6.89B | 3.71B | 564.15M | 648.29M | 4.08 |
![]()
FTDR
Frontdoor Inc
|
59.67 | 4.15B | 1.83B | 234.00M | 235.00M | 3.03 |
Medifast Inc Stock (MED) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-11-05 | Hochstufung | DA Davidson | Underperform → Neutral |
2024-06-05 | Herabstufung | DA Davidson | Neutral → Underperform |
2023-10-13 | Eingeleitet | Stephens | Equal-Weight |
2022-11-04 | Herabstufung | DA Davidson | Buy → Neutral |
2022-08-04 | Herabstufung | Jefferies | Buy → Hold |
2021-01-25 | Hochstufung | Jefferies | Hold → Buy |
2020-11-05 | Hochstufung | DA Davidson | Neutral → Buy |
2020-06-25 | Eingeleitet | B. Riley FBR | Buy |
2020-02-27 | Herabstufung | Jefferies | Buy → Hold |
2019-11-08 | Herabstufung | Dougherty & Company | Buy → Neutral |
2019-07-25 | Eingeleitet | Jefferies | Buy |
2018-11-08 | Hochstufung | Sidoti | Neutral → Buy |
2018-03-07 | Hochstufung | Sidoti | Neutral → Buy |
2017-09-15 | Bestätigt | DA Davidson | Buy |
2016-08-04 | Bestätigt | Wunderlich | Hold |
2016-01-11 | Hochstufung | Sidoti | Neutral → Buy |
2015-11-30 | Herabstufung | Sidoti | Buy → Neutral |
2015-10-05 | Hochstufung | Sidoti | Neutral → Buy |
2014-11-07 | Herabstufung | Imperial Capital | Outperform → In-line |
2014-08-08 | Bestätigt | Imperial Capital | Outperform |
2014-04-23 | Bestätigt | Imperial Capital | Outperform |
2013-09-06 | Eingeleitet | Imperial Capital | Outperform |
2012-11-06 | Bestätigt | Northland Securities | Outperform |
2012-07-27 | Hochstufung | Northland Securities | Market Perform → Outperform |
2012-07-09 | Herabstufung | Standpoint Research | Buy → Hold |
2012-01-30 | Eingeleitet | Standpoint Research | Buy |
Alle ansehen
Medifast Inc Aktie (MED) Neueste Nachrichten
Medifast (MED) Stock Trades Up, Here Is Why - TradingView
5 Insightful Analyst Questions From Medifast’s Q2 Earnings Call - Yahoo Finance
How Medifast Inc. stock performs during market volatilityMonthly Double Digit Returns - classian.co.kr
Medifast Inc Q2 2025 Earnings Call Highlights: Strategic Initiatives Amidst Challenges - AInvest
Medifast's Q2 Earnings Call: Challenges and Optimism Amidst Revenue Decline and Active Coach Reduction - AInvest
Medifast's Q2 Earnings Beat Estimates, Lower Revenues Hurt Margins - MSN
Consumer Staples Sector Resilience Amid Macroeconomic Headwinds: Contrasting Nomad Foods and Medifast's Q2 2025 Performance and Strategic Positioning - AInvest
Medifast, Inc. (NYSE:MED) Q2 2025 Earnings Call Transcript - Insider Monkey
Medifast Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Medifast signals limited use of promotions and unveils Premier+ pricing to drive coach retention - MSN
Why Medifast (MED) Stock Is Up Today - Yahoo Finance
Medifast shares rise 2.37% intraday despite Q2 revenue falling 37%. - AInvest
Medifast Q2 2025 Earnings Call Transcript: Revenue Down 3.7%, Digital Sales Growth Amidst Pandemic - AInvest
Medifast: Q2 Earnings Snapshot - New Haven Register
Medifast Q2 EPS Guidance: 60c-0c, Q3 Revenue $70M-$90M - AInvest
Medifast Inc (MED) Q2 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... By GuruFocus - Investing.com Canada
Medifast’s Revenue Drops As Weight-Loss Shifts Hit Sales - Finimize
Medifast's Q2 2025: Navigating Contradictions in Coach Productivity, Marketing Strategy, and GLP-1 Integration - AInvest
Medifast Reports Q2 2025 Financial Results - TipRanks
MEDIFAST Q2 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: Medifast Q2 2025 sees revenue decline, EPS surprise - Investing.com
Medifast Inc. May Be Forming Higher Low — Chartwatchers AlertSmart Allocation Stock Pick Insights Gaining Interest - metal.it
MEDIFAST INC SEC 10-Q Report - TradingView
Medifast (NYSE:MED) Exceeds Q2 Expectations But Quarterly Revenue Guidance Misses Expectations - Yahoo Finance
MEDIFAST earnings beat by $0.44, revenue topped estimates - Investing.com UK
Medifast Q2 2025 slides: Coach productivity improves amid revenue challenges By Investing.com - Investing.com South Africa
Medifast Q2 2025 slides: Coach productivity improves amid revenue challenges - Investing.com Australia
Medifast Q2 revenue falls 37% - MarketScreener
Medifast Announces Second Quarter 2025 Financial Results - Business Wire
What is the risk reward ratio of investing in Medifast Inc. stockGet expert analysis on top stock picks - Jammu Links News
Is Medifast Gaining or Losing Market Support? - 富途牛牛
Custom Dashboard Highlights Medifast Inc. Price MomentumExit Ready Momentum Stock Watchlist Expanded - beatles.ru
How volatile is Medifast Inc. stock compared to the marketBuild wealth steadily with expert advice - Jammu Links News
Is Medifast Inc. a growth stock or a value stockBuild capital through low-risk investments - Jammu Links News
How many analysts rate Medifast Inc. as a “Buy”Unlock your trading potential with expert tips - Jammu Links News
What drives Medifast Inc. stock priceAchieve superior returns through strategic trading - Jammu Links News
Is it the right time to buy Medifast Inc. stockDiscover the next big stock winners - Jammu Links News
Is Medifast Inc. stock overvalued or undervaluedTrack stocks with high upside potential easily - Jammu Links News
What is the dividend policy of Medifast Inc. stockExplosive returns - Jammu Links News
Does Medifast Inc. stock perform well during market downturnsAchieve breakthrough gains with expert advice - Jammu Links News
How strong is Medifast Inc. company’s balance sheetBuild wealth faster with high-performing stocks - Jammu Links News
What catalysts could drive Medifast Inc. stock higher in 2025Skyrocketing investment returns - Jammu Links News
Should I hold or sell Medifast Inc. stock in 2025Invest confidently with professional market insights - Jammu Links News
What institutional investors are buying Medifast Inc. stockMaximize gains with professional stock picks - Jammu Links News
What are analysts’ price targets for Medifast Inc. in the next 12 monthsHigh-yield portfolio picks - Jammu Links News
Medifast (MED) Q2 Earnings: Can Strategic Shifts Drive a Rebound in a Declining Market? - AInvest
What is Medifast Inc. company’s growth strategyGet alerts on the hottest stocks daily - Jammu Links News
What are Medifast Inc. company’s key revenue driversInvest smarter with expert stock recommendations - Jammu Links News
Medifast (MED) Reports Q2: Everything You Need To Know Ahead Of Earnings - TradingView
Medifast Inc. Stock Analysis and ForecastFree Wealth Management Insights - Jammu Links News
What are the technical indicators suggesting about Medifast Inc.Achieve consistent double-digit growth rates - Jammu Links News
Finanzdaten der Medifast Inc-Aktie (MED)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):